Challenges and Opportunities for Respiratory Syncytial Virus Vaccines
Although respiratory syncytial virus (RSV) has been a high priority for vaccine development for over 50 years now, still no vaccine is available and none has yet demonstrated sufficient promise to move to licensure. The success of RSV immune prophylaxis and the availability of ever more powerful too...
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
|Series:||Current Topics in Microbiology and Immunology,